Drug Related Products

  1. What Could Be The Outcome For Opko Health?

    Investors have pinned high hopes on Opko Health , a development-stage healthcare ...
  2. What Drugs Could Boost Biogen Idec’s Sales?

    Bet against biotechnology giant Biogen Idec and it's likely to sting -- at least ...
  3. Will MannKind Finally Reach A Solid Ground?

    MannKind Corporation has been plagued by setbacks, but this year has turned into ...
  4. Should We Be Concerned For Sarepta’s Share Prices?

    The disease that's caught the attention of a few biotech companies, including Sarepta ...
  5. What Are The Real Economic Costs Of Obesity?

    According to the Centers for Disease Control and Prevention, more than one-third ...
  6. Gilead Sciences: The New Market-Share Leader

    Gilead Sciences's track record of developing and commercializing therapies has turned ...
  1. What Could Be The Outcome For Opko Health?

    Investors have pinned high hopes on Opko Health , a development-stage healthcare ...
  2. What Drugs Could Boost Biogen Idec’s Sales?

    Bet against biotechnology giant Biogen Idec and it's likely to sting -- at least ...
  3. Will MannKind Finally Reach A Solid Ground?

    MannKind Corporation has been plagued by setbacks, but this year has turned into ...
  4. Should We Be Concerned For Sarepta’s Share Prices?

    The disease that's caught the attention of a few biotech companies, including Sarepta ...
  5. What Are The Real Economic Costs Of Obesity?

    According to the Centers for Disease Control and Prevention, more than one-third ...
  6. Gilead Sciences: The New Market-Share Leader

    Gilead Sciences's track record of developing and commercializing therapies has turned ...
  1. Which industries can benefit the most from venture capital?

    Read about the kinds of industries that tend to receive the most venture capital funding and why private equity investors ...
Trading Center